The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Andrés Iñiguez
Showing 1-20 of 24 articles
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabate M
August 5, 2022 | 10.4244/EIJ-D-21-00651
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabate M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M,
Polad J,
Hildick-Smith D,
Bizeau O,
Baisebenov R,
Roffi M,
Iñiguez A,
Chevalier B,
von Birgelen C,
Roguin A,
Aminian A,
Angioi M,
Mamas MA
September 18, 2020 | 10.4244/EIJ-D-20-00361
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S,
Katagiri Y,
Byrne R,
Brugaletta S,
Alfonso F,
Räber L,
Maeng M,
Iñiguez A,
Kretov E,
Onuma Y,
Joner M,
Sabate M,
Laugwitz K,
Windecker S,
Kastrati A,
Serruys P
March 20, 2020 | 10.4244/EIJ-D-18-01080
Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI)
Estévez-Loureiro R,
Adamo M,
Arzamendi D,
Denti P,
Freixa X,
Nombela-Franco L,
Pascual I,
Melica B,
Attias D,
Serrador A,
Benito-González T,
Iñiguez A,
Fernández-Vázquez F
February 20, 2020 | 10.4244/EIJ-D-19-00653
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning AP,
Escaned J,
Wykrzykowska JJ,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabate M,
Windecker S,
Serruys P,
Räber L,
Sabate M,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabate M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial
Wijns W,
Valdés Chávarri M,
Richardt G,
Moreno R,
Iñiguez A,
Barbato E,
Carrié D,
Ando K,
Merkely B,
Kornowski R,
Eltchaninoff H,
Stojkovic S,
Saito S
June 14, 2018 | 10.4244/EIJ-D-18-00358
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial
Paradies V,
Ben-Yehuda O,
Jonas M,
Banai S,
Iñiguez A,
Perlman G,
Kandzari D,
Stone G,
Smits P
May 20, 2018 | 10.4244/EIJ-D-17-00890
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C,
Asano T,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Onuma Y,
Serruys P,
Sabate M
April 20, 2018 | 10.4244/EIJ-D-17-00462
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients
Abu-Assi E,
Raposeiras-Roubin S,
Cobas-Paz R,
Caneiro-Queija B,
Martinez-Reglero C,
Rodriguez-Rodriguez JM,
Baz A,
Iñiguez A
March 20, 2018 | 10.4244/EIJ-D-17-00550
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabate M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabate M,
Windecker S,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Onuma Y,
Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L,
Brugaletta S,
Giacchi G,
Ishida K,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Valgimigli M,
Serruys P,
Sabate M
August 4, 2017 | 10.4244/EIJ-D-16-00512
Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry
Garcia E,
Arzamendi D,
Jiménez-Quevedo P,
Sarnago F,
Martí G,
Sanchez Recalde A,
Lasa-Larraya G,
Sancho M,
Iñiguez A,
Goicolea J,
Roman K,
Alonso-Briales J,
Molina E,
Calabuig J,
Freixa X,
Berenguer A,
Valdés Chávarri M,
Vázquez N,
Diaz J,
Cruz-González I
March 20, 2017 | 10.4244/EIJ-D-16-00581
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L,
Onuma Y,
Brugaletta S,
Garcia-Garcia H,
Backx B,
Iñiguez A,
Jensen L,
Cequier-Fillat A,
Pilgrim T,
Christiansen E,
Hofma S,
Suttorp M,
Serruys P,
Sabate M,
Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry
Iñiguez A,
Brener S,
Jimenez V,
Maehara A,
Mintz G,
Xu K,
Weisz G,
Lansky A,
De Bruyne B,
Serruys P,
Stone G
April 20, 2016 | 10.4244/EIJV11I13A285
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabate M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
1
2
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke